查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
临床检验服务的全球市场:策略和趋势，预测 - 各化验类型，场所，各产品，各国:情形分析，附执行顾问指南(2025年～2029年)
市场调查报告书
商品编码
1597906

临床检验服务的全球市场:策略和趋势，预测 - 各化验类型，场所，各产品，各国:情形分析，附执行顾问指南(2025年～2029年)

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 367 Pages | 商品交期: 最快1-2个工作天内

价格

虽然临床测试面临新冠病毒的挑战，但大流行的结束催生了新的诊断方法。虽然现场护理和自我检测威胁临床检测服务的长期需求，但分子诊断正在推动快速成长。

临床测试将直接受益于生物技术（尤其是基因组学）的爆炸性发展。各种动态趋势正在推动市场成长和公司估值。

本报告提供全球临床检验服务市场相关调查，提供市场概要，以及各化验类型，场所，各产品，各国趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 市场

第2章 简介和市场定义

  • 临床检验新的需求
  • 机会定义
  • 调查手法
  • 观点:医疗保健和IVD产业

第3章 市场概要

  • 市场进入机关
    • 学术研究机关
    • 诊断测试开发商
    • 仪器供应商
    • 药品·试剂厂商
    • 病理供应商
    • 独立型临床检验室
    • 公共的国立/地区研究所
    • 医院检验室
    • 临床检验室
    • 审核机关
    • 认证机关
  • 市场区隔- 各种方法
  • 临床检验产业结构
  • 国家与地区的多样性

第4章 推进不断变化的市场的趋势

  • 推动成长的多个方面
  • 市场缩小的要素
  • 自动化和研究室趋势

第5章 临床检验服务的最近的趋势

第6章 主要企业的简介

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Assurance Scientific Laboratories
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnosticos da America
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories
  • Mid America Clinical Laboratories
  • MNG Labs
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • OncoDNA
  • Pathology, Inc.
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Synlab
  • Sysmex Inostics
  • Unilabs
  • Werfen

第7章 全球临床检验市场

  • 全球市场概要，各国
  • 全球市场概要，各化验类型
  • 全球市场概要，各场所
  • 全球市场概要，各产品

第8章 全球临床检验诊断市场- 各化验类型

  • 化学
  • 微生物学
  • 血液学
  • 解剖病理学
  • 分子诊断
  • 难治性检验

第9章 全球临床检验诊断市场- 场所

  • 住院病房
  • 门诊病人医院
  • 独立研究所
  • 医院检验室
  • 其他

第10章 全球临床检验诊断市场- 各产品

  • 设备
  • 试剂
  • 人事费用
  • 间接费
  • 其他

第11章 临床检验室的未来

第12章 附录

Report Overview:

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. The New Demand for Clinical Testing
  • 2.2. Defining the Opportunity
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Segmentation - Different Approaches
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
  • 3.3. Structure of Clinical Testing Industry
    • 3.3.1. The Hospital Lab - Share of the Pie
    • 3.3.2. Key Role for Economies of Scale
    • 3.3.3. Physician Office Lab's are Still Here
    • 3.3.4. Physician's and POCT - Reviving Patient Service in China
  • 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

  • 4.1. Growth Is Pushed from Many Sides
    • 4.1.1. Demographic Impacts on Consumption
    • 4.1.2. COVID Related Impacts
    • 4.1.3. Point of Care Testing Makes a Difference
    • 4.1.4. Alternative Medicine Effect
    • 4.1.5. Esoterics
    • 4.1.6. A New Laboratory Discipline
  • 4.2. Factors at Work to Shrink the Market
    • 4.2.1. Where are Costs Going?
    • 4.2.2. Population Effects
    • 4.2.3. Management Practices
    • 4.2.4. Wellness
    • 4.2.5. Cannabilization
    • 4.2.6. Point of Care
  • 4.3. Automation and Laboratory Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Siemens Healthineers Reach New Level of Automation
  • 5.3. Clinical Laboratory Prostate Cancer Screening Concerns
  • 5.4. Clinical Labs Prepare for AI
  • 5.5. Self-Testing and AI to Change Clinical Labs
  • 5.6. Atalan Sees Potential in Hospital Outreach Business
  • 5.7. Challenge Bringing Routine Testing to Point of Care
  • 5.8. Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.9. Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.10. MedGenome Acquires Prognosis Laboratories
  • 5.11. Brooks Automation acquires Aim Lab
  • 5.12. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.13. Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.14. CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.15. Quest Diagnostics acquires Summa Health outreach lab
  • 5.16. Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.17. Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.18. Labcorp to Spin Off Clinical Development Business
  • 5.19. Value-Based Care Growing More Profitable for Labs
  • 5.20. Lucid Diagnostics Reports Revenue Growth
  • 5.21. NGS Cancer Testing Decision Appeases Industry
  • 5.22. Clinical Labs Make Strong Showing in 2021
  • 5.23. Seegene to Enter Syndromic MDx Space
  • 5.24. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.25. Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.26. ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.27. Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.28. EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.29. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.30. Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.31. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.32. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.33. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.34. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.35. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

  • 6.1. Acibadem Labmed Laboratory
  • 6.2. ACM Medical Laboratory
  • 6.3. Adicon Clinical Laboratories
  • 6.4. American Bio-Clinical Laboratories, Int'l
  • 6.5. ARUP Laboratories
  • 6.6. Ascend Clinical
  • 6.7. Assurance Scientific Laboratories
  • 6.8. Bio-Reference Laboratories
  • 6.9. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.10. BP Healthcare Group
  • 6.11. Clinical Reference Laboratory
  • 6.12. Clongen Laboratories
  • 6.13. CompuNet Clinical Laboratories
  • 6.14. Diagnosticos da America
  • 6.15. DIAN Diagnostics Co., Ltd.
  • 6.16. Enzo Biochem
  • 6.17. Eone Laboratories
  • 6.18. Eurofins Scientific
  • 6.19. Exagen Diagnostics
  • 6.20. Genzyme Corporation
  • 6.21. Gribbles Pathology
  • 6.22. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.23. Integrated Regional Laboratories
  • 6.24. KDL Group
  • 6.25. Laboratory Corporation of America
  • 6.26. Lifelabs
  • 6.27. Mayo Clinic Laboratories
  • 6.28. Mid America Clinical Laboratories
  • 6.29. MNG Labs
  • 6.30. Myriad Genetics/Myriad RBM
  • 6.31. NeoGenomics
  • 6.32. OncoDNA
  • 6.33. Pathology, Inc.
  • 6.34. ProPhase Labs
  • 6.35. Psychemedics Corporation
  • 6.36. Quest Diagnostics
  • 6.37. RDL Reference Laboratory
  • 6.38. Sonic Healthcare
  • 6.39. Sophia Genetics
  • 6.40. Spectra Laboratories
  • 6.41. Synlab
  • 6.42. Sysmex Inostics
  • 6.43. Unilabs
  • 6.44. Werfen

7. The Global Market for Clinical Laboratory Testing

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country
  • 7.2. Global Market by Assay Type - Overview
    • 7.2.1. Table - Global Market by Assay Type
    • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Assay Type - Base Year
    • 7.2.4. Chart - Global Market by Assay Type - End Year
    • 7.2.5. Chart - Global Market by Assay Type - Share by Year
    • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
  • 7.3. Global Market by Place - Overview
    • 7.3.1. Table - Global Market by Place
    • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Place - Base Year
    • 7.3.4. Chart - Global Market by Place - End Year
    • 7.3.5. Chart - Global Market by Place - Share by Year
    • 7.3.6. Chart - Global Market by Place - Segments Growth
  • 7.4. Global Market by Product - Overview
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3. Chart - Global Market by Product - Base Year
    • 7.4.4. Chart - Global Market by Product - End Year
    • 7.4.5. Chart - Global Market by Product - Share by Year
    • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1. Chemistry
    • 8.1.1. Table Chemistry - by Country
    • 8.1.2. Chart - Chemistry Growth
  • 8.2. Microbiology
    • 8.2.1. Table Microbiology - by Country
    • 8.2.2. Chart - Microbiology Growth
  • 8.3. Hematology
    • 8.3.1. Table Hematology - by Country
    • 8.3.2. Chart - Hematology Growth
  • 8.4. Anatomic Pathology
    • 8.4.1. Table Anatomic Pathology - by Country
    • 8.4.2. Chart - Anatomic Pathology Growth
  • 8.5. Molecular Diagnostics
    • 8.5.1. Table Molecular Diagnostics - by Country
    • 8.5.2. Chart - Molecular Diagnostics Growth
  • 8.6. Esoteric
    • 8.6.1. Table Esoteric - by Country
    • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1. In Patient Hospital
    • 9.1.1. Table In Patient Hospital - by Country
    • 9.1.2. Chart - In Patient Hospital Growth
  • 9.2. Out Patient Hospital
    • 9.2.1. Table Out Patient Hospital - by Country
    • 9.2.2. Chart - Out Patient Hospital Growth
  • 9.3. Independent Laboratory
    • 9.3.1. Table Independent Laboratory - by Country
    • 9.3.2. Chart - Independent Laboratory Growth
  • 9.4. Physicians Office Laboratory
    • 9.4.1. Table Physicians Office Laboratory - by Country
    • 9.4.2. Chart - Physicians Office Laboratory Growth
  • 9.5. Other Laboratory
    • 9.5.1. Table Other Laboratory - by Country
    • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1. Instruments
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instruments Growth
  • 10.2. Reagents
    • 10.2.1. Table Reagents - by Country
    • 10.2.2. Chart - Reagents Growth
  • 10.3. Labour
    • 10.3.1. Table Labour - by Country
    • 10.3.2. Chart - Labour Growth
  • 10.4. Overhead
    • 10.4.1. Table Overhead - by Country
    • 10.4.2. Chart - Overhead Growth
  • 10.5. Other Product
    • 10.5.1. Table Other Product - by Country
    • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus - Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: Factors Affecting Local Clinical Testing Demand
  • Table 6: Seven Factors Driving Growth
  • Table 7: Alternative Medicine Segments
  • Table 8: Six Factors Limiting Growth
  • Table 9: Seven Key Diagnostic Laboratory Technology Trends
  • Table 10 - Global Market by Region
  • Table 11: Global Market by Assay Type
  • Table 12: Global Market by Place
  • Table 13: Global Market by Product
  • Table 14: Chemistry by Country
  • Table 15: Microbiology by Country
  • Table 16: Hematology by Country
  • Table 17: Anatomic Pathology by Country
  • Table 18: Molecular Diagnostics by Country
  • Table 19: Esoteric by Country
  • Table 20: In Patient Hospital by Country
  • Table 21: Out Patient Hospital by Country
  • Table 22: Independent Laboratory by Country
  • Table 23: Physicians Office Laboratory by Country
  • Table 24: Other Laboratory by Country
  • Table 25: Instruments by Country
  • Table 26: Reagents by Country
  • Table 27: Labour by Country
  • Table 28: Overhead by Country
  • Table 29: Other Product by Country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Road to Diagnostics
  • Figure 3: The Changing Age of The World's Population
  • Figure 4: Health Care Consumption by Age
  • Figure 5: Cancer Incidence - Age at Diagnosis
  • Figure 6: Centralized vs. Decentralized Laboratory Service
  • Figure 7: A Highly Multiplexed Syndromic Testing Unit
  • Figure 8: The Real Cost to Sequence the Human Genome
  • Figure 9: The Codevelopment Process
  • Figure 10: Comparing MDx Diagnostic and Traditional Testing
  • Figure 11: Global Market Pareto Chart
  • Figure 12: Global Market by Assay Type - Base vs. Final
  • Figure 13: Global Market by Assay Type Base Year
  • Figure 14: Global Market by Assay Type End Year
  • Figure 15: Assay Type Share by Year
  • Figure 16: Assay Type Segments Growth
  • Figure 17: Global Market by Place - Base vs. Final
  • Figure 18: Global Market by Place Base Year
  • Figure 19: Global Market by Place End Year
  • Figure 20: Place Share by Year
  • Figure 21: Place Segments Growth
  • Figure 22: Global Market by Product - Base vs. Final
  • Figure 23: Global Market by Product Base Year
  • Figure 24: Global Market by Product End Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segments Growth
  • Figure 27: Chemistry Growth
  • Figure 28: Microbiology Growth
  • Figure 29: Hematology Growth
  • Figure 30: Anatomic Pathology Growth
  • Figure 31: Molecular Diagnostics Growth
  • Figure 32: Esoteric Growth
  • Figure 33: In Patient Hospital Growth
  • Figure 34: Out Patient Hospital Growth
  • Figure 35: Independent Laboratory Growth
  • Figure 36: Physicians Office Laboratory Growth
  • Figure 37: Other Laboratory Growth
  • Figure 38: Instruments Growth
  • Figure 39: Reagents Growth
  • Figure 40: Labour Growth
  • Figure 41: Overhead Growth
  • Figure 42: Other Product Growth